Type 2 diabetes management has evolved. It’s no longer just about controlling blood sugar — cardiovascular disease and chronic kidney disease are now front and centre. For adults with diabetes who have kidney issues or elevated cardiovascular risk, focusing on these outcomes can make a meaningful difference
Modern management involves a combination of approaches. Clinicians consider pharmacologic options, lifestyle measures, and regular monitoring to slow disease progression and reduce complications. Medications such as SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists are increasingly important, with their use guided by kidney function, cardiovascular risk, and potential side effects.
Ultimately, the goal is a patient-centered, evidence-informed approach that addresses more than just blood sugar. By thinking beyond glycemic control, clinicians can help patients protect their hearts and kidneys, improving long-term outcomes in a complex and evolving landscape of care.
Prioritizing cardiovascular and renal health alongside glycemic management isn’t optional, it’s central to modern diabetes care. Clinicians who integrate these strategies into routine practice are better positioned to reduce complications and support meaningful, long-term benefits for their patients.